Automated Antimicrobial Susceptibility Testing Market expected to reach USD 4.2 billion in 2025
The Automated Antimicrobial Susceptibility Testing Market is expected to grow at a CAGR of 5.5 percent from USD 3.2 billion in 2020 to USD 4.2 billion in 2025. The rising prevalence of infections caused by bacterial pathogens and antibiotic overuse, which leads to antibiotic resistance in bacterial organisms; the development of better standards for fungal susceptibility; and the growing use of rapid commercial AST systems for fungal testing are all driving the market forward.
COVID-19 Impact on
the global Automated Antimicrobial Susceptibility Testing Market
As a result of the pandemic, access to customers to market and implement automated AST systems (such as the Accelerate Pheno system, MicroScan WalkAway, and Sensitire ARIS system) decreased in March 2020 and during the second quarter of 2020, as hospitals focused solely on the COVID-19 pandemic.Because market players have limited access to present and potential clients, they have been unable to complete sales of new AST systems or install previously sold systems, limiting the expansion of consumable test kits. Furthermore, by the fourth quarter of 2020, the market expects to recoup its losses.
Infectious organisms such as Haemophilus influenzae, Neisseria meningitides, Streptococcus pneumoniae, Shigella, Vibrio cholerae, Neisseria gonorrhoeae, and Salmonella serotype Typhi are driving up demand for antimicrobial susceptibility testing kits. The facts on the increased incidence of various important infections are listed below.
- According to the World Health Organization, tuberculosis is one of the top ten causes of death and the leading cause of death caused by a single infectious agent. In 2018, it was predicted that 10 million individuals worldwide were infected with tuberculosis, with 1.5 million people dying as a result of the disease.
- According to UNAIDS, 1.7 million people were newly infected with HIV in 2019, 38 million people are living with HIV, and 690,000 people died of AIDS-related illnesses.
- According to the World Malaria Report 2019, there were an estimated 228 million cases of malaria identified in the world in 2019. According to the report, about 85% of the global malaria burden was carried by nineteen nations in Sub-Saharan Africa and India.
- Restraint: High cost of automated ID/AST systems
Automated antimicrobial susceptibility testing devices are expensive since they include a lot of advanced features and functions. Incubation and detection times are cut in half when automated AST methods are used. The expensive cost of these systems, on the other hand, is a major impediment to their widespread adoption by end-users, particularly by small-budget institutions.
Comments
Post a Comment